Through this partnership, BioDuro will provide research services in the areas of discovery chemistry and biology, which can help to shorten drug discovery timelines. This agreement is an expansion of an existing relationship.
Robert Goodnow, global head of medicinal chemistry outsourcing at Roche, said: “Presently, there is intense competition within the contract research organization industry for outsourcing and drug discovery services, and the expectation is that they will deliver problem solving skills and innovation in both chemistry and biology. We selected BioDuro due to their demonstrated excellent performance in synthetic chemistry and ability to deliver integrated medicinal chemistry services.”